@misc{indiciae441fdf1e5d08,
  title = {Rapamycin, an Immunosuppressant and mTORC1 Inhibitor, Triples the antidepressant Response Rate of Ketamine at 2 Weeks Following Treatment: A double-blind, placebo-controlled, cross-over, randomized clinical trial},
  author = {Abdallah, C. and Averill, L. A. and Gueorguieva, R. and Goktas, S. and Purohit, P. and Ranganathan, M. and D'Souza, D. C. and Formica, R. and Southwick, S. M. and Duman, R. S. and Sanacora, G. and Krystal, J.},
  year = {2018},
  doi = {10.1101/500959},
  url = {https://www.biorxiv.org/content/10.1101/500959v1},
  note = {Source identifier: 10.1101/500959}
}